UK: First Graphene has announced a third trial at Breedon Group’s Hope Cement Works to test an optimised formulation of its PureGRAPH-CEM product under full-scale production conditions. The trial aims to further improve the performance of graphene nanoplatelets in cement production using practical experiences obtained from the previous two trials. The third trial is based on a PureGRAPH grade with a particle size distribution and morphology optimised for use in cement grinding mills, designed for direct addition to the mill without the need for additional equipment. The trial will last eight hours and involves close monitoring of cement fineness during the process. It will use just over 2t of the graphene product in up to 1000t of cement, according to the company. The trial is scheduled to start in the second quarter of 2024.
First Graphene to trial new graphene product at Breedon's Hope Cement Works
Acquisition
Asia
carbon capture
Cemex
China
CO2
concrete
coronavirus
data
decarbonisation
Export
Germany
Government
grinding plant
Holcim
Import
India
Investment
LafargeHolcim
market
Pakistan
Plant
Product
Production
Results
Sales
Sustainability
UK
Upgrade
US
| « | October 2025 | » | ||||
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
